Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More
Adhesive patch containing and delivering essential and balsamic oils for the symptomatic treatment of the common cold and nasal congestion More
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients. More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Multilayered controlled release oral solid pharmaceutical composition in tablet form suitable for oral administration comprising at least two layers containing active material in association with excipients and additives. More
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals. More
Rheumatoid arthritis More
Two types of vaccines for preventing and treating allergic diseases including atopic dermatitis, allergic asthma, allergic rhinitis, allergic conjunctivitis, and urticaria. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 178 pages - $1,495
Nov 2011 - 7 pages - $3,835
Nov 2010 - 160 pages - $1,495
Jan 2011 - 33 pages - $500
May 2011 - 81 pages - $3,835
Jan 2011 - 28 pages - $1,000
Dec 2010 - 37 pages - $1,000
Jan 2011 - 22 pages - $500
Dec 2010 - 36 pages - $1,000
Oct 2011 - 60 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us